🇺🇸 transdermal nicotine replacement therapy in United States

4 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bipolar I Disorder — 2 reports (50%)
  2. Drug Abuse — 1 report (25%)
  3. Mania — 1 report (25%)

Source database →

transdermal nicotine replacement therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is transdermal nicotine replacement therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for transdermal nicotine replacement therapy in United States?

Duke University is the originator. The local marketing authorisation holder may differ — check the official source linked above.